---
title: "Dichotomous Endpoints"
subtitle: "Description of how to specify the virtual subject response for dichotomous endpoints."
format:
  html:
    toc: true
    toc-depth: 4
    toc-title: "Table of Contents"
    number-sections: true
    number-depth: 4
---

FACTS Core Designs

Dichotomous: Study, Virtual Subject Response, Execution, Simulation and
Analysis tabs and Output file contents.

# Virtual Subject Response

As with all FACTS design engines the Virtual Subject Response tab allows
the user to explicitly define virtual subject response profiles, and/or
to import virtual externally simulated patient responses -- e.g. from a
PK/PD model. When simulations are executed, they will be executed for a
specific scenario -- where a scenario is a combination of one of each
type of profile -- dose response, longitudinal, accrual and dropout. If
an external file is used to specify the subject responses to be
simulated, this effectively replaces the dose response and longitudinal
profiles in a scenario.

In FACTS Core with a dichotomous endpoint there are 4 different
circumstances:

1.  Explicit specification of a dichotomous endpoint

2.  Explicit specification of a restricted Markov endpoint

3.  Explicit specification of a continuous endpoint that is dichotomized
    into responder / non-responder based on the response at the final
    visit.

4.  Importation of an externally generated set of simulated subject
    results.

## Explicitly Defined VSR

With a conventional dichotomous response being simulated, FACTS allows
subject responses to be simulated by specifying the response rate to
simulate.

### Dose Response

![](../coreUGattachments/dichotomous/media/image20.png){width="5.878088363954506in"
height="4.463384733158355in"}

Dose response profiles can be added and deleted, and for each profile
the user specifies:

1.  The response rate for each treatment arm.

2.  A check box that allows the user to specify whether a specific arm
    "should succeed" in that scenario: so that FACTS can report on the
    proportion of simulations that were successful **and** a 'good'
    treatment arm selected.

The graph on the tab shows the mean response rate specified and the
target.

If a 2D treatment arm model is being used, the doses are listed in
"effective dose strength order" as was defined on the treatment arm tab.

#### Load Scenario Rates From File

If the "Load scenario means from a file" option is selected then in
scenarios using this profile the simulations will use a range of dose
responses. Each individual simulation uses one set of response rates
from the supplied file, each row being used in an equal number of
simulations. The summary results are thus averaged over all the VSRs in
the file. The use of this form of simulation is somewhat different from
simulations using a single rate or single external virtual subject
response file. When all the simulations are simulated from one 'truth'
then the purpose of the simulations is to analyse the performance of the
design under that specific circumstance. When the simulations are based
on a range of 'truths' then the summary results show the expected
probability of the different outcomes for the trial over that range of
possible circumstances. Note that to give different VSRs different
weights of expectation, the more likely VSRs should be repeated within
the file.

![](../coreUGattachments/dichotomous/media/image21.png){width="5.312863079615048in"
height="4.034195100612424in"}

After selecting the ".mvsr" file the graph shows the individual response
rates and the mean response rate over all the VSRs.

There is a check box per dose that allows the user to specify whether a
specific arm "should succeed" in that scenario: so that FACTS can report
on the proportion of simulations that were successful **and** a 'good'
treatment arm selected.

The format of the ".mvsr" file is a simple CSV text file. Lines starting
with a '#' character are ignored so the file can include comment and
header lines. There must be one column per treatment arm, and they must
be in dose index order. Each value is the underlying response rate to
simulate. E.g.:

```
#Cntrl, D1, D2, D3, D4
0.05, 0.1, 0.15, 0.25, 0.5
0.05, 0.1, 0.15, 0.23, 0.45
0.05, 0.1, 0.15, 0.21, 0.4
0.05, 0.1, 0.15, 0.19, 0.35
0.05, 0.1, 0.15, 0.17, 0.3
0.05, 0.1, 0.15, 0.15, 0.25
```

If restricted Markov is being used then there must be two sets of
columns, the first giving the overall response rate and the second
giving the overall failure rate. Say the failure rate will be 0.1 for
all doses then the above becomes:

```
#Cntrl, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, Cntrl, 1mg, 5mg, 10mg, 25mg,
50mg, 100mg
0.2, 0.2, 0.2, 0.2, 0.2, 0.2, 0.2, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1
0.2, 0.2, 0.2, 0.17, 0.15, 0.12, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1
0.2, 0.21, 0.22, 0.23, 0.25, 0.27, 0.28, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1,
0.1
0.2, 0.22, 0.22, 0.27, 0.3, 0.32, 0.35, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1,
0.1
0.2, 0.22, 0.24, 0.28, 0.35, 0.4, 0.4, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1
0.2, 0.22, 0.25, 0.35, 0.4, 0.35, 0.3, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1
0.2, 0.3, 0.4, 0.35, 0.3, 0.2, 0.15, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1
```

If a dichotomized continuous endpoint is being used then there must be
two sets of columns, the first giving the mean change from baseline and
the second giving the SD of the change (as in FACTS Core Continuous).
For example with control and 3 doses, and where the SD will be 5 for all
doses in all VSRs:

```
#Means SDs
#Cntrl, D1, D2, D3, Cntrl, D1, D2, D3
-1, -1, -1, -1, 5, 5, 5, 5
-1, -1.2, -1.4, -1.6, 5, 5, 5, 5
-1, -1.8, -2.5, -2.5, 5, 5, 5, 5
-1, -2, -2.5, -3, 5, 5, 5, 5
-1, -2.5, -3.25, -3.25, 5, 5, 5, 5
-1, -2.5, -3.25, -2.5, 5, 5, 5, 5
```

### Longitudinal Simulation

#### Default Dichotomous Longitudinal Simulation Method

The tab for defining dichotomous longitudinal response profiles allows
the user to specify the overall transition probabilities between
responder and non-responder.

If no special longitudinal options are selected on the Study Info page, then
this default simulation method that uses transition probabilities to simulate
sequential dichotomous endpoints is used.

The transition probabilities method for generating longitudinal
responses simulates the response observed at each visit by using the
probability that a subject becomes or remains a '1' from one visit to
the next -- and all subjects start with a response of 0.

![](../coreUGattachments/dichotomous/media/image22.png){width="5.598215223097113in"
height="4.250869422572179in"}

The user specifies for each visit,

-   the probability of a subject whose response was a '0' at the
    previous visit having a response of '1' at this visit

-   the probability of a subject whose response was a '1' at the
    previous visit having a response of '1' at this visit

However, these probabilities imply a particular probability that a
subject has a response of '1' at the final visit, so they need to be
modified for each arm in each dose response profile to give the desired
final probability of response. This is done by numerically determining
for each final response rate, a single value which when
added to all the specified transition probabilities in the log-odds
space yield the desired probability of final response.

Let $Q_{td}$ be the probability of transitioning from 0 to 1, and
$R_{td}$ be the probability of transitioning from 1 to 1 for each visit
(t) and dose (d).

For the 1^st^ visit:

$$P\left( y_{1d} = 1 \right) = Q_{1d}$$

which is like considering the imaginary 0^th^ visit to have been a non-response.
For subsequent visits:

$$P\left( y_{td} = 1 \middle| y_{t - 1,d} = 0 \right) = Q_{td}$$

$$P\left( y_{td} = 1 \middle| y_{t - 1,d} = 1 \right) = R_{td}$$

The dose response ($P_{d}$) is first specified in the VSR \> Explicitly
Defined \> Dose Response tab, and then longitudinal components ($q_{t}$
and $r_{t}$) are specified separately. FACTS then makes an adjustment to
the longitudinal components $q_{t}$ and $r_{t}$ to calculate $Q_{td}$
and $R_{td}$ for each dose while maintaining the value for $P_{d}$
specified in the Dose Response tab.

The matrices Q and R are calculated by applying offsets $f_{d}$ in log
odds space to the longitudinal values:

$Q_{t,d} = \frac{e^{q'_{td}}}{1 + e^{q'_{td}}}$,
$q'_{td} = \ln\left( \frac{q_{t}}{1 + q_{t}} \right) + f_{d}$,

$R_{t,d} = \frac{e^{r'_{td}}}{1 + e^{r'_{td}}}$,
$r'_{td} = \ln\left( \frac{r_{t}}{1 + r_{t}} \right) + f_{d}$

where $f_{d}$ is calculated iteratively for each dose to ensure that Q
and R give the correct final probability of response for each dose. As a
result,

$$P_{d} = x_{Td}$$

where

$$x_{1d} = Q_{1d}$$

and

$$x_{t} = x_{t - 1}R_{td} + \left( 1 - x_{t - 1} \right)Q_{td}$$

**Example**:

With 3 visits and probabilities of $0\rightarrow 1$ of $0.2$ and of $1\rightarrow 1$ of $0.9$ at
each visit, the probability of a final response is 0.438. This 0.438 is fixed,
and cannot be changed without changing the transition probabilities.

  -------------------------------------------------------------------------
                    **Transition
                    probabilities**
  ----------------- ----------------- ------------------ ------------------
  **Response**      **Visit 1**       **Visit 2**        **Visit 3**

  **0**             0.2               0.2                0.2

  **1**             \-                0.9                0.9

                    **Pr(Response)**

  **Response**      **Visit 1**       **Visit 2**        **Visit 3**

  **0**             0.8               0.66               0.562

  **1**             0.2               0.34               0.438
  -------------------------------------------------------------------------

If a response profile calls for the probability of a final response to
be simulated with a probability of 0.8, a fixed offset in log-odds is
found which when applied to all the transition probabilities results in
the desired final probability of a response. Replicating this by hand to
an accuracy of 4 significant digits yields an offset of 1.173, which gives:

  -------------------------------------------------------------------------
                    **Transition
                    probabilities**
  ----------------- ----------------- ------------------ ------------------
  **Response**      **Visit 1**       **Visit 2**        **Visit 3**

  **0**             0.4469            0.4469             0.4469

  **1**             \-                0.9668             0.9668

                    **Pr(Response)**

  **Response**      **Visit 1**       **Visit 2**        **Visit 3**

  **0**             0.5531            0.3208             0.2000

  **1**             0.4469            0.6792             0.8000
  -------------------------------------------------------------------------

#### Restricted Markov Dose Response

If on the Study > Study Info tab, the special longitudinal option of
using the restricted Markov is selected then this tab is available for
specifying jointly how subject interim and final outcomes are to be
simulated:

![](../coreUGattachments/dichotomous/media/image23.png){width="5.427807305336833in"
height="4.121475284339458in"}

Unlike the simulation of the conventional dichotomous outcome, with
Restricted Markov the longitudinal and final response are specified
together.

The Absorbing Markov Chain model assumes at each visit patients are in
one of three states -- responder, stable disease, or failure
(non-responder). The responder and failure states are assumed to be
absorbing, so patients entering one of these states remain in those
states for the duration of the study. Thus, all patient profiles will
consist of some duration of stable disease followed by a permanent
transition to responder or failure. If a subject remains in the stable state
through their final endpoint time, the final response is made
dichotomous by the user specifying whether patients in the stable state
at the final visit should be classified as responders or failures.

For each dose the user specifies the probability that the subject will
be a failure at their final endpoint, and the probability that a subject
will be a responder at their final visit. Given these probabilities,
FACTS can calculate the probability that a subjects is in the stable
state at their final visit, and then the mechanism for generating
subjects longitudinal data is:

1)  Two independent exponentially distributed variables, one measuring
    the time until response $T_{R}$ and another measuring the time until
    failure $T_{F}$, are simulated when the subject enters the study.

2)  If either of variable has a value less than the final endpoint time,
    the engine determines which variable ($T_{R}$ or $T_{F}$) is the
    minimum. All visits whose time occurs less than that minimum are
    stable, while all visits past that variable's time are classified as
    that variable's corresponding state (thus, if visits occur every
    week for 10 weeks, the response variable $T_{R}$ is 4.5, and the
    failure variable $T_{F}$ is 9.5, then the response variable is the
    minimum, visits 1-4 are stable, and visits 5-10 are a response.

3)  If neither variable is less than the final endpoint time, the final
    endpoint and all visits are assumed to be stable.

The parameters of the exponential variables are determined so that they
agree with the user entries for the probabilities of response, stable,
and failure at the final endpoint. Given T is the time of the final
endpoint and a particular dose has probability for response, stable, and
failure of Pr(resp), Pr(stable), and Pr(fail) with Pr(stable) strictly
between 0 and 1, the appropriate exponential parameters (again there are
separate rates in each group and arm) are

$$\lambda_{r} = \frac{\Pr(resp)\left\lbrack - \ln{Pr(stable)} \right\rbrack}{T\left( 1 - Pr(stable) \right)}$$
$$\lambda_{f} = \frac{\Pr(fail)\left\lbrack - \ln{Pr(stable)} \right\rbrack}{T\left( 1 - Pr(stable) \right)}$$

If one of these rates is 0, that random variable is removed from the
calculation (e.g. if Pr(fail)=0 then failures are not generated). If
Pr(stable)=0, the transition to response or failure is assumed to occur
instantaneously after enrolment, and thus a weighted coin is flipped
with probabilities Pr(resp) and Pr(fail) and all visits are equal to the
result (e.g. all visits are responses or all visits are failures
depending on the result of that weighted coin flip). If Pr(stable)=1,
then all visits are stable.

There is a check box per dose that allows the user to specify whether a
specific arm "should succeed" in that scenario so that FACTS can report
on the proportion of simulations that were successful **and** a 'good'
treatment arm selected.

The graph on the Restricted Markov tab shows the probability of response
for each arm and the target CSD relative to the response on control.

#### Dichotomized Continuous Response

If, on the Study > Study Info tab, the special longitudinal option is
selected that the endpoint is a dichotomized continuous response, then instead
of using the dichotomous endpoint infrastructure the [continuous dose response
model](../design/doseresponse.qmd) and
[longitudinal data simulation](../longitudinalmodels/continuous.qmd) tabs are
used. After the final endpoint
and all intermediate endpoints are simulated from the continuous distribution,
they are dichotomized using the threshold specified on the Study Info tab.

##  External

As well as simulating subject responses within FACTS they can be
simulated externally, and imported into
FACTS where the supplied responses are sampled from with replacement
when simulating the trial. The selection of a file containing subject
response data (which must be in the required format) can be done from
the External Files sub-tab depicted below.

To import an external file, the user must first add a profile to the
table. After adding the profile, the user must click "Browse" to locate
the file of externally simulated data. The user will then be prompted to
locate the external file on their computer with a dialog box.

![](../coreUGattachments/dichotomous/media/image24.png){width="5.518231627296588in"
height="4.19013779527559in"}

### Required Format of Externally Simulated Detail

The supplied data should be in the following format: an ascii file with
data in comma separated value format with the following columns:

1)  Patient id - these must be sequential, unique, positive integers.

2)  Arm Index (1 = Control, 2 = Treatment1, 3 = Treatment2, ...)

3)  Visit ID -- visit index (1= first visit, 2= second visit, ...)

4)  Response -- 0 for no response, 1 for response, -1 for stable
        (restricted Markov)

Subjects need to have unique, positive integer IDs, all records for each
subject should be contiguous and in visit order.

The GUI requires that the file name has a ".dat" suffix. Additionally,
it is acceptable to not use column headers in the .dat input file. If
column headers are included, the column header line should begin with a pound
sign (#) indicating it should be ignored.

**Example:** 2 subjects, both assigned to the first arm, data for 6
visits :

+-----------------------+-----------------------+----------------------+
| Dichotomous only      | Restricted Markov     | Continuous           |
+=======================+=======================+======================+
| #subj id, Arm ID,     | #subj id, Arm ID,     | #subj id, Arm ID,    |
| Visit ID, Response    | Visit ID, Response    | Visit ID, Response   |
|                       |                       |                      |
| 1,1,1,0               | 1,1,1,-1              | 1,1,1,1              |
|                       |                       |                      |
| 1,1,2,0               | 1,1,2,-1              | 1,1,2,0              |
|                       |                       |                      |
| 1,1,3,0               | 1,1,3,-1              | 1,1,3,0              |
|                       |                       |                      |
| 1,1,4,1               | 1,1,4,-1              | 1,1,4,0              |
|                       |                       |                      |
| 1,1,5,0               | 1,1,5,-1              | 1,1,5,1              |
|                       |                       |                      |
| 1,1,6,1               | 1,1,6,-1              | 1,1,6,2              |
|                       |                       |                      |
| 2,1,1,1               | 2,1,1,-1              | 2,1,1,1              |
|                       |                       |                      |
| 2,1,2,0               | 2,1,2,0               | 2,1,2,0              |
|                       |                       |                      |
| 2,1,3,0               | 2,1,3,0               | 2,1,3,2              |
|                       |                       |                      |
| 2,1,4,0               | 2,1,4,0               | 2,1,4,1              |
|                       |                       |                      |
| 2,1,5,0               | 2,1,5,0               | 2,1,5,1              |
|                       |                       |                      |
| 2,1,6,0               | 2,1,6,0               | 2,1,6,3              |
+-----------------------+-----------------------+----------------------+

#### External Directory of Files

By using the 'Browse for directory' option, the user can specify a
response profile that comprises a directory containing a number of
external response files. Like the "scenario means in a file" option, the
files in this directory will be used as a single profile, looping
through the different files for successive simulations. So individual
simulations will use a single external file from the directory, but the
summary results for the scenario will be averaged over all the files,
the number of simulations being round down to the nearest multiple of
the number of external files in the directory. The format of each
individual file should be the same as for a single external file, above.
Only files with the ".dat" suffix will be read, other files will be
ignored.

![A screenshot of a social media post Description automatically
generated](../coreUGattachments/dichotomous/media/image25.png){width="5.543155074365704in"
height="4.209061679790026in"}












## Response

+----------+---------+------------------------------------------------+
| Column   | Number  | Description                                    |
| Title    | of      |                                                |
|          | columns |                                                |
+==========+=========+================================================+
| Status   | 1       | This column reports on the current status of   |
|          |         | simulations: Completed, Running, No Results,   |
|          |         | Out of date, Error. It is updated              |
|          |         | automatically.                                 |
+----------+---------+------------------------------------------------+
| Scenario | 1       | This column gives the name of the scenario,    |
|          |         | concatenating together the profile names from  |
|          |         | the following tabs:                            |
|          |         |                                                |
|          |         | 'Execution \> Accrual',                        |
|          |         |                                                |
|          |         | 'Execution \> Dropout Rate',                   |
|          |         |                                                |
|          |         | 'Virtual Subject Response \> Composite,        |
|          |         |                                                |
|          |         | This is the same name as used for the results  |
|          |         | directory                                      |
+----------+---------+------------------------------------------------+
| Mean     | One per | This is the mean (over the simulations) of the |
| Trt.:    | arm     | estimate of the response on this dose.         |
| \<Dose\> |         |                                                |
+----------+---------+------------------------------------------------+
| SD Trt.: | One per | This is the standard deviation (over the       |
| \<Dose\> | arm     | simulations) of the estimate of the response   |
|          |         | on this dose.                                  |
+----------+---------+------------------------------------------------+
| True     | One per | This is the true response rate from which the  |
| Mean     | arm     | simulation data was sampled.                   |
| Resp:    |         |                                                |
| \<Dose\> |         |                                                |
+----------+---------+------------------------------------------------+



## Model Parameters

+----------+---------+------------------------------------------------+
| Column   | Number  | Description                                    |
| Title    | of      |                                                |
|          | columns |                                                |
+==========+=========+================================================+
| Scenario | 1       | This column gives the name of the scenario,    |
|          |         | concatenating together the profile names from  |
|          |         | the following tabs:                            |
|          |         |                                                |
|          |         | 'Execution \> Accrual',                        |
|          |         |                                                |
|          |         | 'Execution \> Dropout Rate',                   |
|          |         |                                                |
|          |         | 'Virtual Subject Response \> Composite,        |
|          |         |                                                |
|          |         | This is the same name as used for the results  |
|          |         | directory                                      |
+----------+---------+------------------------------------------------+
| Mean     | D\*V    | These are only calculated and written out if   |
| Longmod  |         | the ITP longitudinal model is being used.      |
| Resp:    |         |                                                |
| \<Dose\> |         | This is the mean (over the simulations) of the |
| \        |         | estimate of the mean response for a particular |
| <Visit\> |         | dose at a particular visit.                    |
+----------+---------+------------------------------------------------+
| SE Mean  | D\*V    | This is the standard error (over the           |
| Longmod  |         | simulations) of the longitudinal model         |
| Resp:    |         | estimate of the response at intermediate       |
| \<Dose\> |         | visits (see above)                             |
| \        |         |                                                |
| <Visit\> |         |                                                |
+----------+---------+------------------------------------------------+
| BAC Mean | 1       | This is the mean (over the simulations) of the |
|          |         | posterior estimate of the mean of the Bayesian |
|          |         | Augmented Control (Hierarchical Prior)         |
|          |         | distribution of mean control responses.        |
+----------+---------+------------------------------------------------+
| SD BAC   | 1       | This is the SD (over the simulations) of the   |
| Mean     |         | posterior estimate of the mean of the Bayesian |
|          |         | Augmented Control (Hierarchical Prior)         |
|          |         | distribution of mean control responses.        |
+----------+---------+------------------------------------------------+
| BAC Tau  | 1       | This is the mean (over the simulations) of the |
|          |         | posterior estimate of the SD of the Bayesian   |
|          |         | Augmented Control (Hierarchical Prior)         |
|          |         | distribution of mean control responses.        |
+----------+---------+------------------------------------------------+
| SD BAC   | 1       | This is the SD (over the simulations) of the   |
| tau      |         | posterior estimate of the SD of the Bayesian   |
|          |         | Augmented Control (Hierarchical Prior)         |
|          |         | distribution of mean control responses.        |
+----------+---------+------------------------------------------------+
| BAAC     | 1       | This is the mean (over the simulations) of the |
| Mean     |         | posterior estimate of the mean of the Bayesian |
|          |         | Augmented Active Comparator (Hierarchical      |
|          |         | Prior) distribution of mean active comparator  |
|          |         | responses.                                     |
+----------+---------+------------------------------------------------+
| SD BAAC  | 1       | This is the SD (over the simulations) of the   |
| Mean     |         | posterior estimate of the mean of the Bayesian |
|          |         | Augmented Active Comparator (Hierarchical      |
|          |         | Prior) distribution of mean control responses. |
+----------+---------+------------------------------------------------+
| BAAC Tau | 1       | This is the mean (over the simulations) of the |
|          |         | posterior estimate of the SD of the Bayesian   |
|          |         | Augmented Active Comparator (Hierarchical      |
|          |         | Prior) distribution of mean active comparator  |
|          |         | responses.                                     |
+----------+---------+------------------------------------------------+
| SD BAAC  | 1       | This is the SD (over the simulations) of the   |
| tau      |         | posterior estimate of the SD of the Bayesian   |
|          |         | Augmented Active Comparator (Hierarchical      |
|          |         | Prior) distribution of mean active comparator  |
|          |         | responses.                                     |
+----------+---------+------------------------------------------------+


## Entering the data directly

For a typical FACTS Core trial, there are normally too many subjects to
want to enter the data directly, but it is possible. Also if data is
first loaded from an external file, it is presented in the same grid as
that used for data entry and additional data can be added or existing
data modified.

The data format is the same as the 'patientsNNNN.csv' output file from
simulations, so it is easy to use these as the basis for a trial
analysis.

-   The first column is the Subject ID. FACTS does not use this value,
    it is there to allow the data to be cross-referenced to an external
    data source. If not required there is no harm simply entering '1' on
    each row.

-   Region ID is a value output from FACTS simulation, reflecting the
    recruiting region the simulated subject was recruited in. It is not
    used in analysis, if a region ID is not available there is no harm
    simply entering '1' for each subject.

-   Date is a real number indicating when the subject was recruited in
    weeks[^5] from the start of the trial. It is output from FACTS
    simulation, it is not used in analysis. If a date is not available
    there is no harm simply entering '1' for each subject.

-   Dose index indicates which arm the subject was randomized to. The
    index of each arm is visible on the Study \> Treatment Arms tab.
    Index '1' is the Control arm if a Control is present.

-   Last Visit# is the index of last visit for which there is data for
    the subject. Previously FACTS could not process data with data
    missing from visits before the last visit. From FACTS 6.2 this is
    now possible. Visits for which no data is available should be given
    the value "-9999". Data supplied for a subject's visits after 'Last
    Visit#' is ignored.

-   Dropout, is a flag, value '0' (not dropped out) or '1' (dropped
    out). For s subject that has dropped out, FACTS will apply the
    defined value for the subject from the 'Last Visit#'.

-   Baseline, this should be the subjects baseline score in Dichotomous,
    baseline is ignored it must always be 0.

-   Visit1-... these are the subjects response values at the defined
    visits (on the Study tab), up to and including the final visit. For
    a dichotomous endpoint, these values are either 0 (no response) or 1
    (response).

![](../coreUGattachments/dichotomous/media/image78.png){width="5.021865704286964in"
height="3.8132338145231848in"}

If data is entered and then 'Run Analysis' clicked, the data is saved to
a file called 'patients.dat' and the analysis results saved to a folder
called 'Analysis' within the "\_results" folder of the design.

![](../coreUGattachments/dichotomous/media/image79.png){width="5.011838363954506in"
height="2.4154527559055117in"}

The 'Save As' button can be used to save the file with a different name,
but it will still be saved within the \_Results folder.

A specific results folder is also created, called 'Analysis\_\<file
name\>'.

## Loading Data From a File

As well as entering the data via FACTS its possible to load the data
from a 'subject.csv' file. These can be created within FACTS or outside
of FACTS and once created can be edited FACTS or outside of FACTS.

We have tried to make it particularly easy to enter, modify and analyze
data in N-CRM because this is a useful way to explore the properties of
the design in addition to simulation.

### The subject.csv file format

The file is a simple ascii file with the different data items separated
by commas. Any line starting with '#'' is ignored, here we use that to
include a header row. The data may also include spaces to aid
readability (but **not**, currently, tabs). Each line defines the dose
given to a single subject and that subject's response.

The format of the file is the same as the 'patientsNNNN.csv' output
file, (Section 18.5 below) and the column values described above.

### Converting arrival date value from days to weeks

From FACTS 7.0 the value in the Date field is interpreted as being in
weeks (rather than days as in previous versions). If you have existing
data, a simple conversion tool is provided "Convert Date from Days to
Weeks" that simply divides all the Date values by 7. Having run it, you
then need to save the modified data. The values of the Date field will
only make a difference to TTE analyses.

![Graphical user interface, application Description automatically
generated](../coreUGattachments/dichotomous/media/image80.png){width="5.014107611548557in"
height="3.8073425196850392in"} ![Table Description automatically
generated with medium
confidence](../coreUGattachments/dichotomous/media/image81.png){width="0.46625984251968505in"
height="2.0403477690288714in"}

## Data file management on the Analysis tab

From FACTS 6.2 onwards FACTS now supports multiple subject data files
and analysis folders.

Buttons that allow the subject data file to be changed:

-   'Select File to Create New Analysis: launches a file browser that
    allows the user to select a new ".csv" file from any location. The
    selected file is copied to the "\_Results" folder (retaining its
    current name) and made the current subject data file.

-   'Rename Current Analysis' allows the name of the current subject
    data file to be changed.

-   'Select Difference Analysis' allows a different subject data file
    that is in the "\_Results" folder to be made the current subject
    data file.

-   'Delete Analysis' allows any of the subject data files that are in
    the "\_Results" folder to be deleted.

The name of the current subject data file and the name of the
corresponding analysis folder are shown below the subject data file
buttons.

There are five buttons that allow the currently loaded subject data file
to be modified:

-   'Delete Row' deletes the currently selected row in the data grid.
    The data in the current subject file is not updated unless the
    current data is saved.

-   'Delete All' clears all the data in the data grid. The data in the
    current subject file is not updated unless the current data is
    saved.

-   'Reload data' replaces the data in the data grid with the data that
    is still in the current subject data file.

-   'Save As' saves the current data in the data grid to a new subject
    data file in the "\_Results" folder, and makes that the current
    subject data file.

-   "Save" saves the current data in the data grid to the current
    subject data file.

Running an analysis performs a 'Save' before running the analysis.

## Running an Analysis

Once data has been loaded or entered, the user can click the 'Run
Analysis' button.

Once the analysis has run, FACTS displays the recommendation, and a
graph showing the data.

![](../coreUGattachments/dichotomous/media/image82.png){width="5.032169728783902in"
height="3.821058617672791in"}

## Analysis Options

At the top of the analysis tab there are various parameters that can be
set to control the analysis performed:

![](../coreUGattachments/dichotomous/media/image83.png){width="6.944271653543307in"
height="2.0564009186351706in"}

-   The MCMC parameters

    -   "Burn-in" for the number of initial samples that are discarded

    -   "Length" for the number of samples drawn to form the posterior
        distributions

    -   Random number seed that can be set to generate a different
        sampling sequence

    -   Whether an MCMC file is to be output (which enables the ability
        to view sample history graphs for the model parameters).

    -   Edit command line parameters allows expert users to enter
        command line parameters to be passed to the design engine that
        are not settable through this panel.

    -   It is possible to flag which, if any, doses have already been
        dropped and hence to be excluded from future adaptation
        decisions, but included in the analysis (this can be used even
        if the design is not an arm dropping design -- to allow for an
        arm being dropped for reasons outside the scope of the
        simulation, such as logistical or safety reasons.

    -   The user specifies which interim the analysis is for and hence
        which decision criteria to be applied

        -   The user supplied the interim analysis number or

        -   Selects "Do Final Analysis" which causes the analysis to use
            the final evaluation success/futility criteria.

    -   The user specifies the current week of the trial if the amount
        if information defined by "opportunity to complete" is required.

    -   If this is an arm dropping design, it is possible to flag which,
        if any, doses have already been dropped and hence to be excluded
        from future adaptation decisions, but included in the analysis
        \[this can be used even if the design is not an arm dropping
        design -- to allow for an arm being dropped for reasons outside
        the scope of the simulation, such as logistical or safety
        reasons but only be entering the '-armsdropped' command line
        parameter the control is only displayed if the design includes
        arm dropping\].

# Detailed Simulation Results

After simulation has completed and simulation results have been loaded,
the user may examine detailed results for any scenario with simulation
data in the table by double-clicking on the row. A separate window (as
in Figure 15â€‘1) displays the individual results for each simulation.
This is the contents of the "simulations.csv" file, which is described
below. . The simulations results are partitioned into the same various
results groupings as the summary results. These can be accessed from the
"right click" menu, along with opening the results folder, opening the
weeks file for a particular simulation and opening the simulated
patients file for a particular simulation (where a "weeks" file or a
"patients" file has been output).

![](../coreUGattachments/dichotomous/media/image84.png){width="5.367924321959755in"
height="2.7556496062992126in"}

# Output Files

FACTS stores the results of simulations as '.csv' files under a Results
folder. For each row in the simulations table, there is a folder named
by the profiles that make up the scenario, which contains the
corresponding '.csv' files.

![](../coreUGattachments/dichotomous/media/image85.png){width="5.2805708661417325in"
height="2.673570647419073in"}

These files can be opened using Microsoft Excel, but versions of Excel
before 2007 are restricted to 256 columns, which is too few to view some
files in their entirety. The 'Calc' application in 'OpenOffice' will
show all the columns (and will open two files that have the same name at
the same time!). Because Excel takes out a file lock on any file it has
open, while a file is open in Excel it cannot be deleted or modified by
another application. The most common cause for an error to be reported
when simulating trials in FACTS is because the user has one of the
previous results files is still open in Excel.

In the scenario directory there are the following types of results file:

**Summary.csv** Contains a single row of data that summarizes the
simulation results. This is the source of the shown on the simulations
tab.

**Summary_freq_locf.csv**

**Summary_freq_fail.csv**

**Summary_freq_ignore.csv** Contains a single row of data that that
summarizes the frequentist analysis of the simulations. A file is output
for each of the different methods for dealing with missing data that are
applicable: "fail", LOCF and "ignore" (referred to as PP (Per-Protocol)
in the GUI).

**Simulations.csv** Contains one row per simulation describing the final
state of each simulation for every trial simulated.

**Simulations_freq.csv** Contains one row per simulation describing the
frequentist analysis of the final state of each simulation for every
trial simulated.

**PatientsNNNNN.csv** Contains one row per patient in a simulation,
where NNNNN is the number of the simulation. By default this file is
written out only for the first simulation, but this can be changed via
the simulations tab.

**WeeksNNNNN.csv** contains one row for each cohort during a simulation
where NNN is the number of the simulation. By default this file is
written only for the first 100 simulations, but this can be changed on
the simulation tab. The values in the last row of the cohorts file will
be the same as the final values for that simulation in the simulations
file.

## Contents of summary.csv

The first line is a header line, starting with a '#', containing the
column headings.

+----------+---------+------------------------------------------------+
| Column   | Number  | Description                                    |
| Title    | of      |                                                |
|          | columns |                                                |
+==========+=========+================================================+
| Project  | 1       | The name of the facts file                     |
+----------+---------+------------------------------------------------+
| Scenario | 1       | The name of the scenario                       |
+----------+---------+------------------------------------------------+
| T        | 1       | The time the simulations were run              |
| imestamp |         |                                                |
+----------+---------+------------------------------------------------+
| Version  | 1       | The version of FACTC that was used to run the  |
|          |         | simulations                                    |
+----------+---------+------------------------------------------------+
| NSim     | 1       | The number of simulation run.                  |
+----------+---------+------------------------------------------------+
| No. Subj | 1       | The mean, over the simulations, of the total   |
|          |         | number of subjects recruited in the trial.     |
+----------+---------+------------------------------------------------+
| SE Subj. | 1       | The standard error of the total number of      |
|          |         | subjects recruited into the trials.            |
+----------+---------+------------------------------------------------+
| No.Subj  | 1       | The 80^th^ percentile, over the simulations,   |
| 80%ile   |         | of the total number of subjects recruited in   |
|          |         | the trial.                                     |
+----------+---------+------------------------------------------------+
| P(ES)    | > 1     | The proportion of simulations that stopped     |
|          |         | early for success.                             |
+----------+---------+------------------------------------------------+
| P(LS)    | 1       | The proportion of simulations that did not     |
|          |         | stop early, and were successful on final       |
|          |         | evaluation.                                    |
+----------+---------+------------------------------------------------+
| P(LF)    | 1       | The proportion of simulations that did not     |
|          |         | stop early, and were futile on final           |
|          |         | evaluation.                                    |
+----------+---------+------------------------------------------------+
| P(EF)    | 1       | The proportion of simulations that stopped     |
|          |         | early for futility.                            |
+----------+---------+------------------------------------------------+
| SFFF     | 1       | The proportion of simulations that stopped     |
|          |         | early for success, but at final analysis were  |
|          |         | futile (Success-Futility 'flip-flops').        |
+----------+---------+------------------------------------------------+
| FSFF     | 1       | The proportion of simulations that stopped     |
|          |         | early for futility, but at final analysis were |
|          |         | successful (Futility- Success 'flip-flops').   |
+----------+---------+------------------------------------------------+
| Undec.   | 1       | The proportion of simulations that did not     |
|          |         | stop early, and met neither the success or     |
|          |         | futility final evaluation criteria and hence   |
|          |         | are counted as 'undecided'.                    |
+----------+---------+------------------------------------------------+
| Unused   | 3       | Three unused columns for other outcome types.  |
+----------+---------+------------------------------------------------+
| Early    | 1       | This is the mean early decision time (over the |
| Success  |         | simulations stopped early for success), it is  |
| Time     |         | the time from the start of the trial to the    |
|          |         | interim where early success was declared. It   |
|          |         | does not include the subsequent follow up      |
|          |         | time.                                          |
+----------+---------+------------------------------------------------+
| Mean     | D       | The mean (over the simulations) of the number  |
| Alloc    |         | of subjects allocated to each treatment arm.   |
| \<dose\> |         |                                                |
+----------+---------+------------------------------------------------+
| SE Alloc | D       | The standard error (over the simulations) of   |
| \<dose\> |         | the number of subjects allocated to each       |
|          |         | treatment arm.                                 |
+----------+---------+------------------------------------------------+
| Mean     | D       | The mean of the estimates of response of each  |
| Resp     |         | treatment arm.                                 |
| \<dose\> |         |                                                |
+----------+---------+------------------------------------------------+
| SE Resp  | D       | The standard error, over the simulations, of   |
| \<dose\> |         | the estimate of response of each treatment     |
|          |         | arm.                                           |
+----------+---------+------------------------------------------------+
| True     | D       | The true response for each treatment arm used  |
| Mean     |         | when sampling the simulated subject responses. |
| resp     |         |                                                |
| \<dose\> |         |                                                |
+----------+---------+------------------------------------------------+
| Mean     | D\*V    | These are only calculated and written out if   |
| Longmod  |         | the ITP longitudinal model is being used.      |
| Resp:    |         |                                                |
| \<Dose\> |         | This is the mean (over the simulations) of the |
| \        |         | estimate of the mean response for a particular |
| <Visit\> |         | dose at a particular visit.                    |
+----------+---------+------------------------------------------------+
| SE Mean  | D\*V    | This is the standard error (over the           |
| Longmod  |         | simulations) of the longitudinal model         |
| Resp:    |         | estimate of the response at intermediate       |
| \<Dose\> |         | visits (see above)                             |
| \        |         |                                                |
| <Visit\> |         |                                                |
+----------+---------+------------------------------------------------+
| No.      | D\*V    | These are the mean (over the simulations)      |
| Dropouts |         | number of subjects that have dropped out on    |
| \<Dose\> |         | this dose at this visit.                       |
| \        |         |                                                |
| <Visit\> |         |                                                |
+----------+---------+------------------------------------------------+
| BAC Mean | 1       | If a hierarchical prior for Control is being   |
|          |         | used this is the mean (over the simulations)   |
|          |         | of the posterior estimate of the mean of the   |
|          |         | Bayesian Augmented Control (Hierarchical       |
|          |         | Prior) distribution of mean control responses. |
+----------+---------+------------------------------------------------+
| SE of    | 1       | If a hierarchical prior for Control is being   |
| BAC Mean |         | used this is the standard error (over the      |
|          |         | simulations) of the posterior estimate of the  |
|          |         | mean of the Bayesian Augmented Control         |
|          |         | (Hierarchical Prior) distribution of mean      |
|          |         | control responses.                             |
+----------+---------+------------------------------------------------+
| BAC Tau  | 1       | If a hierarchical prior for Control is being   |
|          |         | used this is the mean (over the simulations)   |
|          |         | of the posterior estimate of the SD of the     |
|          |         | Bayesian Augmented Control (Hierarchical       |
|          |         | Prior) distribution of mean control responses. |
+----------+---------+------------------------------------------------+
| SE of    | 1       | If a hierarchical prior for Control is being   |
| BAC Tau  |         | used this is the standard error (over the      |
|          |         | simulations) of the posterior estimate of the  |
|          |         | SD of the Bayesian Augmented Control           |
|          |         | (Hierarchical Prior) distribution of mean      |
|          |         | control responses.                             |
+----------+---------+------------------------------------------------+
| BAAC     | 1       | If a hierarchical prior for Active Comparator  |
| Mean     |         | is being used this is the mean (over the       |
|          |         | simulations) of the posterior estimate of the  |
|          |         | mean of the Bayesian Augmented Active          |
|          |         | Comparator (Hierarchical Prior) distribution   |
|          |         | of mean active comparator responses.           |
+----------+---------+------------------------------------------------+
| SE of    | 1       | If a hierarchical prior for Active Comparator  |
| BAAC     |         | is being used this is the standard error (over |
| Mean     |         | the simulations) of the posterior estimate of  |
|          |         | the mean of the Bayesian Augmented Active      |
|          |         | Comparator (Hierarchical Prior) distribution   |
|          |         | of mean control responses.                     |
+----------+---------+------------------------------------------------+
| BAAC Tau | 1       | If a hierarchical prior for Active Comparator  |
|          |         | is being used this is the mean (over the       |
|          |         | simulations) of the posterior estimate of the  |
|          |         | SD of the Bayesian Augmented Active Comparator |
|          |         | (Hierarchical Prior) distribution of mean      |
|          |         | active comparator responses.                   |
+----------+---------+------------------------------------------------+
| SE of    | 1       | If a hierarchical prior for Active Comparator  |
| BAAC Tau |         | is being used this is the standard error (over |
|          |         | the simulations) of the posterior estimate of  |
|          |         | the SD of the Bayesian Augmented Active        |
|          |         | Comparator (Hierarchical Prior) distribution   |
|          |         | of mean active comparator responses.           |
+----------+---------+------------------------------------------------+
| Mean     | 1       | The mean, over the simulations, of the overall |
| Duration |         | duration of the trials, from first person      |
|          |         | first visit, to last person last visit.        |
+----------+---------+------------------------------------------------+
| Ppn Arms | D       | The proportion of the simulations in which     |
| Dropped  |         | each arm was dropped. These will be zero if    |
| \<dose\> |         | arm dropping is not selected as the means of   |
|          |         | adaptive allocation.                           |
+----------+---------+------------------------------------------------+
| Mean     | 1       | The mean, over the simulations, of the accrual |
| LPFV     |         | period of the trials, from first person first  |
| time     |         | visit, to last person first visit (LPFV).      |
+----------+---------+------------------------------------------------+
| QOI      |         |                                                |
| Columns  |         |                                                |
+----------+---------+------------------------------------------------+

: Figure 6â€‘6 The Variants tab, specifying 5 variants

### QOI Columns

The QOI columns depend on the QOIs that have been defined for this
design. The columns in the following order:

Posterior Probabilities The summary file contains the mean (over the
simulations) of the posterior probability for each dose.

Predictive Probabilities The summary file contains the mean (over the
simulations) of the predictive probability for each dose.

P-Values The summary file contains the mean (over the simulations) of
the p-value for each dose.

Target Probabilities The summary file contains the proportion of times
(over the simulations) each dose had the greatest probability of being
the target.

Decision QOIs The summary file contains the mean (over the simulations)
of the final value of the decision QOI at the target.

## Contents of Summary_freq\_\<missing\>.csv

There is a frequentist summary file for each type of treatment of
missing values.

The first line is a header line, starting with a '#', and containing

-   The FACTS GUI version number

-   The name of the FACTS file

-   The name of the scenario

-   The time stamp of the start of the simulation

The second line is a header line, starting with a '#', containing the
column headings.

+----------+---------+------------------------------------------------+
| Column   | Number  | Description                                    |
| Title    | of      |                                                |
|          | columns |                                                |
+==========+=========+================================================+
| Mean     | D       | The mean response per dose.                    |
| Theta    |         |                                                |
| \<dose\> |         |                                                |
+----------+---------+------------------------------------------------+
| SE Theta | D       | The standard error of the response per dose    |
| \<dose\> |         |                                                |
+----------+---------+------------------------------------------------+
| Ppn      | 1       | The proportion of simulations where at least   |
| Signif   |         | one of the unadjusted p-values is less than    |
|          |         | the user specified one-sided alpha.            |
+----------+---------+------------------------------------------------+
| Ppn      | D       | For each treatment arm, the proportion of      |
| Signif   |         | simulations where the unadjusted p-value is    |
| \<dose\> |         | less than the user specified one-sided alpha.  |
|          |         |                                                |
|          |         | The marginal probability of significance per   |
|          |         | dose (using unadjusted p-values.               |
+----------+---------+------------------------------------------------+
| Bias     | D       | The difference between the mean response and   |
| \<dose\> |         | the true (simulated) response per dose         |
+----------+---------+------------------------------------------------+
| Coverage | D       | The proportion of simulations where the        |
| \<dose\> |         | unadjusted confidence interval for the         |
|          |         | response contains the true response rate used  |
|          |         | to simulate subject responses.                 |
+----------+---------+------------------------------------------------+
| Ppn      | 1       | The proportion of simulations where at least   |
| Signif   |         | one of the Dunnett adjusted p-values is less   |
| Dunnett  |         | than the user specified one-sided alpha.       |
+----------+---------+------------------------------------------------+
| Ppn      | D       | For each treatment arm, the proportion of      |
| Signif   |         | simulations where the Dunnett adjusted p-value |
| Dunnett  |         | is less than the user specified one-sided      |
| \<dose\> |         | alpha.                                         |
+----------+---------+------------------------------------------------+
| Coverage | D       | The proportion of simulations where the        |
| Dunnett  |         | Dunnett adjusted confidence interval contains  |
| \<dose\> |         | the true response rate used to simulate        |
|          |         | subjects responses.                            |
+----------+---------+------------------------------------------------+
| Ppn      | 1       | The proportion of simulations where at least   |
| Signif   |         | one of the Bonferroni adjusted p-values is     |
| Bonf     |         | less than the user specified one-sided alpha.  |
+----------+---------+------------------------------------------------+
| Ppn      | D       | For each treatment arm, the proportion of      |
| Signif   |         | simulations where the Bonferroni adjusted      |
| Bonf     |         | p-value is less than the user specified        |
| \<dose\> |         | one-sided alpha.                               |
+----------+---------+------------------------------------------------+
| Coverage | D       | The proportion of simulations where the        |
| Bonf     |         | Bonferroni adjusted confidence interval        |
| \<dose\> |         | contains the true response rate used to        |
|          |         | simulate subjects responses.                   |
+----------+---------+------------------------------------------------+
| Ppn      | 1       | The proportion of simulations where the trend  |
| Signif   |         | test p-value is less than the user specified   |
| Trend    |         | one-sided alpha.                               |
+----------+---------+------------------------------------------------+

: Figure 7â€‘1: Explicitly Defined Dose Response -- Dichotomous

## Contents of simulations.csv and weeksNNNNN.csv

The simulations.csv file holds the FACTS summary of the final analysis
for each simulation (one per row).

The weeksNNNNN.csv file holds the FACTS summary of every analysis for
the NNNNN^th^ simulation. It contains a row for each interim in the
trial and a roe for the final analysis (Interim number 999). The final
analysis occurs after all the planned data is collected.

-   If the trial does not stop early this will be after all full
    follow-up for all subjects,

-   if the trial does stop early this will be either

<!-- -->

-   an analysis after full follow-up of the subjects recruited up to the
    point of the interim when the stopping decision was taken (If the
    "continue follow-up" option has been selected by the user on the
    Interims tab)

-   or it will perform a repeat the analysis using the data available at
    the interim when the stopping decision was taken -- the results will
    vary from those of the interim within MCMC sampling error. (This
    "unnecessary" analysis is included to keep the content of the weeks
    files consistent and hence simplify the post processing of "weeks"
    files).

The first line is a header line, starting with a '#', and containing

-   The FACTS GUI version number

-   The name of the FACTS file

-   The name of the scenario

-   The time stamp of the start of the simulation

The second line is a header line, starting with a '#', containing the
column headings.

Most of the columns are common to the two file types, but the weeks file
does not contain columns for the 'final' values of the evaluation
criteria.

+-------------+------+-------+----+----------------------------------+
| Column      | Nu   | In    | In | Description                      |
| Title       | mber | s     | w  |                                  |
|             | of   | imula | ee |                                  |
|             | col  | tions | ks |                                  |
|             | umns | file  | fi |                                  |
|             |      |       | le |                                  |
+=============+======+=======+====+==================================+
| \# Weeks    | 1    |       | âœ”  | The week of the analysis         |
| (Duration)  |      |       |    |                                  |
+-------------+------+-------+----+----------------------------------+
| #Sim        | 1    | âœ”     |    | The number of the simulation.    |
+-------------+------+-------+----+----------------------------------+
| LastInterim | 1    | âœ”     |    | The index of the last interim    |
|             |      |       |    | performed the index of the       |
|             |      |       |    | interim immediately before the   |
|             |      |       |    | final interim (index '999').     |
|             |      |       |    | Note this is not necessarily the |
|             |      |       |    | interim when the trial stopped   |
|             |      |       |    | if the design includes follow-up |
|             |      |       |    | after stopping.                  |
+-------------+------+-------+----+----------------------------------+
| #Subjects   | 1    | âœ”     | âœ”  | The number of subjects recruited |
|             |      |       |    | in the simulation.               |
+-------------+------+-------+----+----------------------------------+
| Outcome     | 1    | âœ”     | âœ”  | A flag categorizing final study  |
|             |      |       |    | outcome:                         |
|             |      |       |    |                                  |
|             |      |       |    | 1.  = Early success              |
|             |      |       |    |                                  |
|             |      |       |    | 2.  = Late success               |
|             |      |       |    |                                  |
|             |      |       |    | 3.  = Late futility              |
|             |      |       |    |                                  |
|             |      |       |    | 4.  = Early futility             |
|             |      |       |    |                                  |
|             |      |       |    | 5.  = Success to futility        |
|             |      |       |    |     flip-flop                    |
|             |      |       |    |                                  |
|             |      |       |    | 6.  = Futility to success        |
|             |      |       |    |     flip-flop                    |
|             |      |       |    |                                  |
|             |      |       |    | 7.  = Inconclusive               |
+-------------+------+-------+----+----------------------------------+
| Early       | 1    | âœ”     | âœ”  | This is the time to the early    |
| Success     |      |       |    | success decision (-9999 if there |
| Time        |      |       |    | was no early success decision).  |
|             |      |       |    | The from the start of the trial  |
|             |      |       |    | to the interim where the early   |
|             |      |       |    | success conditions were first    |
|             |      |       |    | met. It does not include the     |
|             |      |       |    | subsequent follow up time.       |
+-------------+------+-------+----+----------------------------------+
| Alloc       | D    | âœ”     | âœ”  | The number of subjects allocated |
| \<dose\>    |      |       |    | to each arm.                     |
+-------------+------+-------+----+----------------------------------+
| Pr(Alloc)   | D    | âœ”     | âœ”  | The probability of allocation to |
| \<dose\>    |      |       |    | the different arms following the |
|             |      |       |    | interim.                         |
+-------------+------+-------+----+----------------------------------+
| Mean resp   | D    | âœ”     | âœ”  | The estimated response of each   |
| \<dose\>    |      |       |    | treatment arm.                   |
+-------------+------+-------+----+----------------------------------+
| SD resp     | D    | âœ”     | âœ”  | The standard deviation of the    |
| \<dose\>    |      |       |    | estimate of response of each     |
|             |      |       |    | treatment arm.                   |
+-------------+------+-------+----+----------------------------------+
| Mean resp   | D    | âœ”     | âœ”  | The lower bound of the 95%       |
| (lower CI)  |      |       |    | Credible Interval of the         |
| \<dose\>    |      |       |    | estimate of response for each    |
|             |      |       |    | treatment arm.                   |
+-------------+------+-------+----+----------------------------------+
| Mean resp   | D    | âœ”     | âœ”  | The upper bound of the 95%       |
| (upper CI)  |      |       |    | Credible Interval of the         |
| \<dose\>    |      |       |    | estimate of response for each    |
|             |      |       |    | treatment arm.                   |
+-------------+------+-------+----+----------------------------------+
| True Mean   | D    | âœ”     | âœ”  | The true mean response of each   |
| resp        |      |       |    | treatment arm for this           |
| \<dose\>    |      |       |    | simulation.                      |
+-------------+------+-------+----+----------------------------------+
| Mean Raw    | D    | âœ”     | âœ”  | The observed rate of response on |
| Response    |      |       |    | each treatment arm (unadjusted   |
| \<dose\>    |      |       |    | by any modeling).                |
+-------------+------+-------+----+----------------------------------+
| Complete    | D    | âœ”     | âœ”  | The number of completed subjects |
| \<dose\>    |      |       |    | on each treatment arm at the     |
|             |      |       |    | time of the analysis.            |
+-------------+------+-------+----+----------------------------------+
| Complete    |      |       |    |                                  |
| Information |      |       |    |                                  |
| \<dose\>    |      |       |    |                                  |
+-------------+------+-------+----+----------------------------------+
| #Dropouts   | D \* | âœ”     | âœ”  | The number of subjects dropped   |
| \<dose\>    | V    |       |    | out on each treatment arm and    |
| \<visit\>   |      |       |    | each visit.                      |
+-------------+------+-------+----+----------------------------------+
| DR Param    | 4    | âœ”     | âœ”  | The estimate of the mean value   |
| \<param\>   |      |       |    | of each of the response model    |
|             |      |       |    | parameters. The response models  |
|             |      |       |    | require up to 4 parameters, some |
|             |      |       |    | less. The model parameters are   |
|             |      |       |    | labeled Î±~1~, Î±~2~, .. the       |
|             |      |       |    | subscripts corresponding to the  |
|             |      |       |    | column their value appears in    |
|             |      |       |    | here.                            |
+-------------+------+-------+----+----------------------------------+
| Sd DR Param | 4    | âœ”     | âœ”  | The standard deviation of the    |
| \<param\>   |      |       |    | estimate of the mean value of    |
|             |      |       |    | the corresponding response model |
|             |      |       |    | parameter.                       |
+-------------+------+-------+----+----------------------------------+
| Longmod\_   | LM   | âœ”     | âœ”  | The estimate of the mean value   |
| \<model\>   | \*   |       |    | of each of the longitudinal      |
| \<          | LMP  |       |    | model parameters. The number of  |
| parameter\> | \* V |       |    | models depends on the number of  |
| \<visit\>   |      |       |    | "model instances" the user has   |
|             |      |       |    | specified. Each value is         |
|             |      |       |    | reported per visit unless        |
|             |      |       |    | otherwise stated.                |
|             |      |       |    |                                  |
|             |      |       |    | For Beta-Binomial the parameters |
|             |      |       |    | reported are:                    |
|             |      |       |    |                                  |
|             |      |       |    | -   Alpha0 & Beta 0 -- The beta  |
|             |      |       |    |     binomial alpha & beta        |
|             |      |       |    |     parameters for the           |
|             |      |       |    |     probability that the final   |
|             |      |       |    |     result will be 1 if the      |
|             |      |       |    |     result at the visit is 0     |
|             |      |       |    |                                  |
|             |      |       |    | -   Prob01 -- the mean           |
|             |      |       |    |     probability of the           |
|             |      |       |    |     Beta(Alpha0, Beta0) -- the   |
|             |      |       |    |     probability of 1 being the   |
|             |      |       |    |     final result if the result   |
|             |      |       |    |     at the visit is 0            |
|             |      |       |    |                                  |
|             |      |       |    | -   Alpha1 & Beta 1 -- The beta  |
|             |      |       |    |     binomial alpha & beta        |
|             |      |       |    |     parameters for the           |
|             |      |       |    |     probability that the final   |
|             |      |       |    |     result will be 1 if the      |
|             |      |       |    |     result at the visit is 1     |
|             |      |       |    |                                  |
|             |      |       |    | -   Prob11 -- the mean           |
|             |      |       |    |     probability of the           |
|             |      |       |    |     Beta(Alpha1, Beta1) -- the   |
|             |      |       |    |     probability of 1 being the   |
|             |      |       |    |     final result if the result   |
|             |      |       |    |     at the visit is 1            |
|             |      |       |    |                                  |
|             |      |       |    | For logistic regression the      |
|             |      |       |    | parameters reported are:         |
|             |      |       |    |                                  |
|             |      |       |    | -   Prob11 -- the probability of |
|             |      |       |    |     1 being the final result if  |
|             |      |       |    |     the result at the visit is   |
|             |      |       |    |     1and                         |
|             |      |       |    |                                  |
|             |      |       |    | -   Prob01 -- the probability of |
|             |      |       |    |     1 being the final result if  |
|             |      |       |    |     the result at the visit is 0 |
|             |      |       |    |                                  |
|             |      |       |    | For restricted Markov the        |
|             |      |       |    | parameters reported are:         |
|             |      |       |    |                                  |
|             |      |       |    | -   Alpha0 -- Alpha for state 0  |
|             |      |       |    |                                  |
|             |      |       |    | -   AlphaS -- Alpha for stable   |
|             |      |       |    |     state                        |
|             |      |       |    |                                  |
|             |      |       |    | -   Alpha1 -- Alpha for state 1  |
|             |      |       |    |                                  |
|             |      |       |    | -   Prob0 -- Transition          |
|             |      |       |    |     probability to state 0       |
|             |      |       |    |                                  |
|             |      |       |    | -   ProbS -- Probability of      |
|             |      |       |    |     remaining stable             |
|             |      |       |    |                                  |
|             |      |       |    | -   Prob1 -- Transition          |
|             |      |       |    |     probability to state 1       |
|             |      |       |    |                                  |
|             |      |       |    | (values are for the transition   |
|             |      |       |    | to the next visit, so thre are   |
|             |      |       |    | no values for the final visit)   |
|             |      |       |    |                                  |
|             |      |       |    | If using a dichotomized          |
|             |      |       |    | continuous response, these       |
|             |      |       |    | columns will be for the selected |
|             |      |       |    | continuous longitudinal model:   |
|             |      |       |    |                                  |
|             |      |       |    | For linear regression the        |
|             |      |       |    | parameters reported are:         |
|             |      |       |    |                                  |
|             |      |       |    | -   Alpha -- the mean estimate   |
|             |      |       |    |     of the constant offset in    |
|             |      |       |    |     the change in response from  |
|             |      |       |    |     this visit to the final      |
|             |      |       |    |     visit                        |
|             |      |       |    |                                  |
|             |      |       |    | -   Beta -- the mean estimate of |
|             |      |       |    |     the coefficient of change in |
|             |      |       |    |     response from this visit to  |
|             |      |       |    |     the final visit              |
|             |      |       |    |                                  |
|             |      |       |    | -   Lambda -- the mean estimate  |
|             |      |       |    |     of the SD of the residual    |
|             |      |       |    |     error term in the predicted  |
|             |      |       |    |     final visit response based   |
|             |      |       |    |     on the response at this      |
|             |      |       |    |     visit.                       |
|             |      |       |    |                                  |
|             |      |       |    | For ITP the parameters are:      |
|             |      |       |    |                                  |
|             |      |       |    | -   K -- single value per model  |
|             |      |       |    |     -- the mean estimate of the  |
|             |      |       |    |     ITP shape parameter          |
|             |      |       |    |                                  |
|             |      |       |    | -   Tau -- single value per      |
|             |      |       |    |     model - the mean estimate of |
|             |      |       |    |     the SD of the per subject    |
|             |      |       |    |     random effect                |
|             |      |       |    |                                  |
|             |      |       |    | -   Lambda -- single value per   |
|             |      |       |    |     model -- the mean estimate   |
|             |      |       |    |     of the Sd of the residual    |
|             |      |       |    |     error.                       |
|             |      |       |    |                                  |
|             |      |       |    | -   Omega -- per treatment arm   |
|             |      |       |    |     not visit -- the mean        |
|             |      |       |    |     estimate of the mean         |
|             |      |       |    |     treatment arm effect.        |
|             |      |       |    |                                  |
|             |      |       |    | For LOCF & Kernel Density there  |
|             |      |       |    | are no estimated parameters.     |
+-------------+------+-------+----+----------------------------------+
| Longmod     | D \* | âœ”     | âœ”  | These are only calculated and    |
| Resp:       | V    |       |    | written out if the ITP           |
| \<Dose\>    |      |       |    | longitudinal model is being used |
| \<Visit\>   |      |       |    | for a dichotomized continuous    |
|             |      |       |    | endpoint.                        |
|             |      |       |    |                                  |
|             |      |       |    | This is the mean response for a  |
|             |      |       |    | particular dose at a particular  |
|             |      |       |    | visit.                           |
+-------------+------+-------+----+----------------------------------+
| BAC Mean    | 1    | âœ”     | âœ”  | This is the posterior estimate   |
|             |      |       |    | of the mean of the Bayesian      |
|             |      |       |    | Augmented Control (Hierarchical  |
|             |      |       |    | Prior) distribution of mean      |
|             |      |       |    | control responses.               |
+-------------+------+-------+----+----------------------------------+
| BAC Mean SD | 1    | âœ”     | âœ”  | This is the SD of the posterior  |
|             |      |       |    | estimate of the mean of the      |
|             |      |       |    | Bayesian Augmented Control       |
|             |      |       |    | (Hierarchical Prior)             |
|             |      |       |    | distribution of mean control     |
|             |      |       |    | responses.                       |
+-------------+------+-------+----+----------------------------------+
| BAC Tau     | 1    | âœ”     | âœ”  | This is the posterior estimate   |
|             |      |       |    | of the SD of the Bayesian        |
|             |      |       |    | Augmented Control (Hierarchical  |
|             |      |       |    | Prior) distribution of mean      |
|             |      |       |    | control responses.               |
+-------------+------+-------+----+----------------------------------+
| BAC Tau SD  | 1    | âœ”     | âœ”  | This is the SD of the posterior  |
|             |      |       |    | estimate of the SD of the        |
|             |      |       |    | Bayesian Augmented Control       |
|             |      |       |    | (Hierarchical Prior)             |
|             |      |       |    | distribution of mean control     |
|             |      |       |    | responses.                       |
+-------------+------+-------+----+----------------------------------+
| BAAC Mean   | 1    | âœ”     | âœ”  | This is the posterior estimate   |
|             |      |       |    | of the mean of the Bayesian      |
|             |      |       |    | Augmented Active Comparator      |
|             |      |       |    | (Hierarchical Prior)             |
|             |      |       |    | distribution of mean active      |
|             |      |       |    | comparator responses.            |
+-------------+------+-------+----+----------------------------------+
| BAAC Mean   | 1    | âœ”     | âœ”  | This is the SD of the posterior  |
| SD          |      |       |    | estimate of the mean of the      |
|             |      |       |    | Bayesian Augmented Active        |
|             |      |       |    | Comparator (Hierarchical Prior)  |
|             |      |       |    | distribution of mean comparator  |
|             |      |       |    | responses.                       |
+-------------+------+-------+----+----------------------------------+
| BAAC Tau    | 1    | âœ”     | âœ”  | This is the posterior estimate   |
|             |      |       |    | of the SD of the Bayesian        |
|             |      |       |    | Augmented Active Comparator      |
|             |      |       |    | (Hierarchical Prior)             |
|             |      |       |    | distribution of mean active      |
|             |      |       |    | comparator responses.            |
+-------------+------+-------+----+----------------------------------+
| BAAC Tau SD | 1    | âœ”     | âœ”  | This is the SD of the posterior  |
|             |      |       |    | estimate of the SD of the        |
|             |      |       |    | Bayesian Augmented Active        |
|             |      |       |    | Comparator (Hierarchical Prior)  |
|             |      |       |    | distribution of mean active      |
|             |      |       |    | comparator responses.            |
+-------------+------+-------+----+----------------------------------+
| Duration    | 1    | âœ”     | âœ”  | The time in weeks to the         |
|             |      |       |    | analysis shown.                  |
+-------------+------+-------+----+----------------------------------+
| Arm Drop    | D    | âœ”     | âœ”  | For each treatment arm, the time |
| Time        |      |       |    | in weeks when it was decided to  |
| \<dose\>    |      |       |    | drop the arm.                    |
+-------------+------+-------+----+----------------------------------+
| LPFV        | 1    | âœ”     | âœ”  | The time in weeks to the last    |
|             |      |       |    | patient first visit.             |
+-------------+------+-------+----+----------------------------------+
| QOI Columns |      |       |    |                                  |
+-------------+------+-------+----+----------------------------------+

: Figure 7â€‘2 Dose Response -- Loading scenario rates in an external file

### QOI Columns

The QOI columns depend on the QOIs that have been defined for this
design. The columns are grouped in the following order:

Posterior Probabilities The posterior probability for each QOI for each
dose.

Predictive Probabilities The predictive probability for each QOI for
each dose.

P-Values The p-value for each QOI for each dose.

Target Probabilities The probability of being the target for each QOI
for each dose.

Decision QOIs The value of the decision QOI at the target.

Success

Futile A flag for each QOI decision criteria indicating if the decision
QOI was evaluated and compared to a threshold at the interim (weeks
file) or final analysis (simulation file). The flag value is -1 if the
decision QOI was not evaluated, 0 if it did not meet the threshold and 1
if it did.

Success / Futile Combined A flag indicating if the interim or final
analysis determined success or futility taking all the factors defined
for Success/Futility into account: 0 if the conditions were not met, 1
it the conditions were met. If success and futility conditions have been
defined that are not mutually exclusive and both sets of combined
conditions are met, FACTS will pick one of the outcomes as met but not
the other. In order to discourage defining Success and Futility rules
that can both be true FACTS does not guarantee which outcome will be
selected.

## Contents of Simulations_freq\_\<missing\>.csv, Weeks_freq\_\<missing\>.csv

These file contain the frequentist results after an interim analysis
(weeks file) or final analysis (simulations file), apart for the first
column, the columns are the same in the two types of file, and the same
across the different methods for treating missing data.

  -----------------------------------------------------------------------
  Column      Number of Description
  Title       columns
  ----------- --------- -------------------------------------------------
  \# Trial    1         The number of the simulation.
                        (simulations_freq\_\...csv only)

  #Weeks      1         The week of the interim (weeks_freq\_\...csv
                        only)

  Theta       D         Unadjusted estimate of response per treatment arm
  \<dose\>

  Theta SD    D         The SD of the estimate of response per treatment
  \<dose\>              arm

  Trt Effect  D         The relative size of the treatment effect
  \<dose\>              compared to control per arm (treatment effect for
                        control is always 0). The direction of the
                        comparison takes into account whether a response
                        represents a subject's condition improving or
                        worsening, so that a positive treatment effect
                        shows the response on the dose is better than on
                        control.

  t-Stat      D         The test statistic per treatment arm (for control
  \<dose\>              this is always 0)

  p-Value     D         The unadjusted test statistic p-value per arm
  \<dose\>              (for control this is always 0)

  lower CI    D         The unadjusted lower bound of the alpha
  \<dose\>              confidence interval of the estimated treatment
                        effect per treatment arm (for control this is
                        always 0).

  upper CI    D         The unadjusted upper bound of the alpha
  \<dose\>              confidence interval of the estimated treatment
                        effect per treatment arm (for control this is
                        always 0).

  Min p-Value 1         The smallest of the test statistic p-values

  p-Value     D         The Dunnett adjusted test statistic p-value per
  Dunnett               arm (for control this is always 0).
  \<dose\>

  lower CI    D         The Dunnett adjusted lower bound of the alpha
  Dunnett               confidence interval of the estimated treatment
  \<dose\>              effect (for control this is always 0).

  upper CI    D         The Dunnett adjusted upper bound of the alpha
  Dunnett               confidence interval of the estimated treatment
  \<dose\>              effect (for control this is always 0).

  Min p-Value 1         The smallest of the Dunnett adjusted p-values.
  Dunnett

  p-Value     D         The Bonferroni adjusted test statistic p-value
  Bonf                  per arm.
  \<dose\>

  lower-CI    D         The Bonferroni adjusted lower bound of the alpha
  Bonf                  confidence interval of the estimated treatment
  \<dose\>              effect (for control this is always 0).

  upper-CI    D         The Bonferroni adjusted upper bound of the alpha
  Bonf                  confidence interval of the estimated treatment
  \<dose\>              effect (for control this is always 0).

  Min p-Value 1         The smallest of the Bonferroni adjusted test
  Bonf                  statistic value per arm.

  t-Stat      1         The t statistic from the trend test.
  trend

  p-Value     1         The p-value from the trend test.
  trend
  -----------------------------------------------------------------------

  : Figure 7â€‘3: Virtual Subject Dichotomous Longitudinal Response

## Contents of PatientsNNNNN.csv

  -------------------------------------------------------------------------
  Column Title Number of  Description
               columns
  ------------ ---------- -------------------------------------------------
  #Subject     1          The subject id number, starting at 1.

  Region       1          Which region the subject was recruited in

  Date         1          The date, in weeks from the start of the trial,
                          of the subject's baseline visit and
                          randomization.

  Dose         1          The index number (1, ...) of the treatment arm
                          the subject belongs to.

  LastVisit#              The index of the last visit for which the
                          subjects data was collected, if the subject did
                          not complete this could be because the subject
                          dropped-out, the subject's treatment arm was
                          dropped (and there was no follow-up) or the study
                          stopped early (and there was no follow-up).

  Baseline     1          -9999 there is no baseline for subjects in a
                          dichotomous response trial.

  Visit        V          Subjects response at each visit
  \<visit\>
  -------------------------------------------------------------------------

  : Figure 7â€‘4: Restricted Markov Dose Response

## Contents of MCMCNNNNN.csv

The MCMC file if requested for output by the user, contains all the MCMC
samples for the fitted parameters in the design. There is one row per
sample (including the burnin) and the samples from all the analyses in
the simulation are included. The first two columns are the analysis
index and the sample (within analysis) index. The remaining columns are
the parameters whose sample values are being reported, the number and
constituents of these columns are highly variable depending on design of
the statistical analysis.

### Content if using a conventional Dichotomous endpoint

  ------------------------------------------------------------------------
  Column      Number of  Description
  Title       columns
  ----------- ---------- -------------------------------------------------
  Analysis    1          The index of the analysis (interim) in the
                         simulation

  Sample      1          The index of the sample within the analysis

  Pi \<dose\> D          The estimate of the response rate for each dose,
                         based on the dose response model fitted

  A \<1-8\> / P          If the dose response model estimates parameters
  Tau                    then the samples of these are listed next. The
                         number and name of the parameters will vary
                         depending on the model being fitted. Check the
                         Design \> Dose Response tab for a listing of the
                         parameters.

  Longmod     L \* P \*  If the analysis includes longitudinal modelling
  \<model\>   V          then the samples of the parameters of the
  \<param\>              longitudinal models are output. The number of
  \<visit\>              models depends on the number of different
                         longitudinal fits the user has specified (one
                         over all arms, one for control and one for all
                         treatment arms, model all arms separately, etc.),
                         the number of parameters the model has, and if
                         these are fitted per visit (which depends on the
                         model being fitted), then the number of visits.
  ------------------------------------------------------------------------

  : Figure 7â€‘9: External Data

### Contents if using a Restricted Markov endpoint

  ------------------------------------------------------------------------
  Column      Number of  Description
  Title       columns
  ----------- ---------- -------------------------------------------------
  Analysis    1          The index of the analysis (interim) in the
                         simulation

  Sample      1          The index of the sample within the analysis

  Pi \<Dose\> D          The estimate of the response rate for each dose,
                         based on the dose response model fitted

  A \<1-8\> / P          If the dose response model estimates parameters
  Tau                    then the samples of these are listed next. The
                         number and name of the parameters will vary
                         depending on the model being fitted. Check the
                         Design \> Dose Response tab for a listing of the
                         parameters.

  Longmod     L \* P \*  Currently the values of Alpha0, Alpha1, AlphaS
  \<model\>   V          (the parameters to the Dirichlet distribution)
  \<param\>              are (unnecessarily -- these values are not
  \<visit\>              sampled) output, along with the values for P0, P1
                         and PS the transition probabilities of each model
                         at each visit.
  ------------------------------------------------------------------------

  : Figure 7â€‘10 External Data directory

### Contents if using a Dichotomized Continuous variable

These are the same as for the Dichotomous endpoint, but the LM
parameters are for the LM of the continuous response value.
